New-Zealand BROMOCRIPTINE | 25614-03-3 supplier

Details for BROMOCRIPTINE

BROMOCRIPTINE

111Category:

Pharmaceuticals and Biochemicals

CAS NO:

25614-03-3

EC NO:

247-128-5

Molecular Formula:

C₃₂H₄₀BrN₅O₅

Molecular Weight:

654.5945

Specification:

For the treatment of Parkinson disease; lactation suppressant; menstrual and pre-menstrual disorders.

InChI:

InChI=1/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1

Product description:

Bromocriptine is a brominated ergot derivative that functions as a dopamine D2 receptor agonist and a dopamine D1 receptor antagonist. It imposes a direct dopaminergic effect on cells located within the basal ganglia, mesolimbic system and hypothal

Synonyms:

2-Bromo-alpha-ergocryptine;Kripton;Parlodel;Bromocriptine;(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman;

Molecular Structure:

if you are sourcing BROMOCRIPTINE from New-Zealand ,just feel free to inquire

Inquire